Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis

By Swartz T.A.   Handsher R.   Manor Y.   Stoeckel P.   Barkay A.   Mendelson E.   Leventhal A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 2090-2095

Elsevier

Access to resources Recommend Favorite

Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine

By Nirmal S.   Cherian T.   Samuel B.U.   Rajasingh J.   Raghupathy P.   John T.J.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 928-931

Elsevier

Access to resources Recommend Favorite

Inactivated hepatitis A vaccine booster given =<24 months after the primary dose

By Landry P.   Tremblay S.   Darioli R.   Genton B.  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 399-402

Elsevier

Access to resources Recommend Favorite

Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other ''travellers'' vaccines with the immune response

By Bienzle U.   Bock H.L.   Kruppenbacher J.P.   Hofmann F.   Vogel G.E.   Clemens R.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 501-505

Elsevier

Access to resources Recommend Favorite

Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine

By Carlsson R.-M.R.-M.   Claesson B.A.   Kayhty H.   Selstam U.   Iwarson S.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 468-478

Elsevier

Access to resources Recommend Favorite